Top Tech Companies (772)
Don't see your company?
Create a company profile
A global leader in developing and producing responsible packaging for food, beverage, pharma, medical, home- and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content.
Who We Are Triangle Insights Group is a strategy consulting firm providing guidance on the most critical business issues to leaders in life sciences organizations. The firm’s approach combines deep knowledge of the industry, across therapeutic areas and functional groups, with a dedication to creativity and strong critical thinking. Recommendations from Triangle Insights Group are original, relevant to the industry environment, and supported by rigorous analytics. Our Vision Our goal is ambitious: to redefine how you think about life sciences consultancies. To replace confusion with clarity. To deliver insights and strategies that foster confidence. Through every step of our customized approaches, you’ll benefit from the personal attention of an entire team of accomplished advisors —their collective vision, collaborative approach and total commitment. Our History Triangle Insights Group, established in April 2013, is an entrepreneurial company. The founding partners are experienced strategy consultants whose backgrounds include Campbell Alliance, Mercer, Boston Consulting Group, and Boston Healthcare. In 2022, the firm was acquired by TrialCard.
MedPharm is a world-leading contract provider of topical and transdermal product design and development services. Our delivery of robust and innovative research has commanded recognition from regulators and investors alike. We utilise our unique cost-effective performance testing models to mitigate risk and accelerate development times.
Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For 30 years, we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapies for hallucinations and delusions associated with Parkinson’s disease psychosis and for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Alzheimer’s disease psychosis and neuropsychiatric symptoms in central nervous system disorders. Important Notice for Candidates - Be Aware of Fraudulent Recruiting Activity Acadia Pharmaceuticals has become aware of fraudulent recruiting activity being circulated via email and LinkedIn by individuals impersonating Acadia Talent Acquisition employees. These communications may appear legitimate due to an official-looking Acadia email address or website, referencing of an actual recruiter and/or manager at Acadia (easily found on LinkedIn), and/or offer documents falsely signed by an Acadia executive. The impostor uses the incentive of a job interview and job offer to solicit sensitive personal information from the intended victim. Please note that the Acadia Talent Acquisition and HR Team will ONLY interact with a candidate from "Acadia-pharm.com" domain sourced emails. We do not request sensitive personal information, such as a Social Security Number, or payments of any kind during the interview or job offer process. Acadia strongly recommends individuals, who receive email solicitations, to carefully verify the authenticity of the correspondence before responding. Never provide personal information or click on links if you are unsure a communication’s legitimacy. If in doubt, please contact [email protected] to verify.
At QuartzBio, we help overcome the data chaos inherent in modern drug development. We serve clinical operations and translational research teams in oncology, autoimmune, CNS and other biomarker-rich therapeutic areas, whose progress hinges on navigating and connecting a complex data ecosystem. Our suite of fully connected, end-to-end SaaS solutions is engineered specifically to address the challenges of both sample data and biomarker data management -- providing a single, scalable data platform solution to the biotech and pharma sectors. We invite you to connect with our experienced, multidisciplinary, global team – we're industry leaders in biomarker data management, clinical operations, and translational informatics, with a focus on precision medicine. Our team members’ wide-ranging specialties include data management, biostatistics, immunology, and genomics. Send us a message, we’d love to chat
Magellan Health is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators.
Turning Point Therapeutics is a structure-based drug design pharmaceutical company.
Sparrow Pharmaceuticals is developing targeted therapies for conditions of corticosteroid excess - associated with either the natural corticosteroid cortisol due to a tumor or long-term use of a corticosteroid drug such as prednisone. Sparrow's pipeline is led by SPI-62 in Phase 2 clinical development.
At the heart of iA, we are passionate about pharmacy. Everything we do is designed to enable pharmacists to make a difference in the health and wellbeing of their patients. With over 25 years in the pharmacy fulfillment business, we have invented and developed a suite of leading-edge software enabled pharmacy fulfillment solutions. From our intelligent Pharmacy Operations Software Platform, to our modular and sophisticated counting and collation devices and our strategic partners, iA can run the prescription fulfillment process from end-to-end, helping pharmacies manage fulfillment and inventory to help lower costs, improve efficiency, and provide comprehensive Rx tracking and real-time support. For centralized fulfillment or pharmacy operations, let us focus on your prescription fulfillment so your pharmacists can focus on patient-facing care. iA is unleashing the full potential of pharmacy
Cylene Pharmaceuticals discovers, develops and commercializes small molecule drugs that target nucleolus and kill cancer cells.
.jpeg)
.png)
Imricor Medical Systems develops magnetic resonance imaging compatible electrophysiology tools for the treatment of cardiac arrhythmias.
Phrixus Pharmaceuticals develops and commercializes heart failure-related pharmaceutical products and therapies.
At Padagis our focus is on health care products that improve people’s lives. We are experts on extended topical products and are strategically investing to expand our #1 position in the extended topical category in the United States. Our team members, numbering more than 1,300 work in a dynamic environment where opportunity is built on a foundation of honesty and transparency.
Tergus Pharma is an end-to-end service provider for topical pharmaceutical products supporting early phase research and formulation, drug development, testing, and both clinical and commercial manufacturing at our new 100,000 sq. ft. state-of-the-art facility in Durham, North Carolina. Tergus is the industry leader for topical/skin semi-solids and liquids as well as other non-skin semi-solids/liquids for vaginal, rectal and otic/ophthalmic routes of administration where we recognize the value of our stellar industry reputation for delivering quality results to clients. With industry-recognized leadership and expertise in method development, such as IVRT/IVPT for topical pharmaceuticals, Tergus also provides clients with peace of mind and helps them to de-risk their product development. Exclusively focused on topical development and manufacturing, Tergus brings the scientific expertise that helps our clients achieve the right balance of scientific knowhow, speed of results, and quality in product service, warranting our company motto, “Think Topicals, Think Tergus.
Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2023, Verve was recognized as a "Best Places to Work" by the Boston Globe. Verve is headquartered in Boston, Massachusetts
Anaphore is developing protein pharmaceuticals to address significant unmet medical needs for patients with serious diseases. RuiYi is a Wholly Foreign-Owned Enterprise (WFOE) located in the Zhangjiang Hi-Tech Park in Pudong Shanghai, China. RuiYi is developing biologic therapies that target G protein coupled receptors (GPCRs).
Pulmotect develops products that boost the innate immune system to protect against a wide range of lung infections.
Sinapis Pharma is a clinical stage biotechnology company that has identified a new use and route of administration for methamphetamine.
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs.
Lena Biosciences is a biotechnology company offering advanced, organ-on-a-chip and 3D cell culture products for precision therapy testing.
